Andreas Gebert / Reuters Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. (REUTERS/Andreas Gebert)BERLIN (Reuters) - Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine. German government sources told Reuters on Sunday that the U.S. administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac. “In this regard, the government is in intensive exchange with the company CureVac,” she added. Welt am Sonntag said CureVac declined to comment.

Source: Huffington Post March 15, 2020 13:52 UTC